Daniel Spelman

Daniel Spelman is a Senior Analyst at Hudson Bay Capital Management LP, based in New York, where he is responsible for generating investment research and supporting alpha generation across multiple strategies. In this role, he focuses on deep fundamental analysis, idea generation, and portfolio management support, contributing to the firm's investment decision-making process.

His expertise lies primarily in equity research, where he covers sectors and companies with a strong emphasis on public equities and event-driven investment strategies. Daniel’s analytical approach encompasses both fundamental and quantitative methods to identify mispriced securities and special situation investments within U.S. and global markets.

Prior to joining Hudson Bay Capital Management LP, Daniel held positions in equity sales and research at firms such as Syneos Health, further building his capabilities in market analysis and investor relations. Widely recognized for his meticulous research efforts, Daniel leverages over a decade of experience in the financial sector to provide his team with actionable insights, with particular strengths in healthcare and technology sectors. He holds advanced degrees in finance, underscoring his technical proficiency and commitment to investment excellence.